Suchergebnisse - "2494G1JF75"

PubPharm (1.792)

71

Effects of Drugs Formerly Suggested for COVID-19 Repurposing on Pannexin1 Channels

enthalten in: International journal of molecular sciences | 2022

von Caufriez, A. | Tabernilla, A. | Van Campenhout, R. | +8

72

Letter to the Editor : Pharmacokinetics of Lopinavir/Ritonavir in Hospitalized Patients with COVID-19 Not Requiring Critical Care

enthalten in: Microbial drug resistance (Larchmont, N.Y.) | 2022

von MacGowan, A. | Hamilton, F. | Bayliss, M. | +8

CommentOn: Ann Intern Med. 2020 Oct 20;173(8):670-672. - PMID 32422065

73

Slower Recovery with Early Lopinavir/Ritonavir use in Pediatric COVID-19 Patients : A Retrospective Observational Study

enthalten in: Paediatric drugs | 2022

von Wong, C. | Low, M. | Kwok, A. | +8

74

Quality of life and associated factors among people receiving second-line anti-retroviral therapy in Johannesburg, South Africa

enthalten in: BMC infectious diseases | 2022

von Mokgethi, N. | Christofides, N. | Machisa, M. | +2

75

Agreement of treatment effects from observational studies and randomized controlled trials evaluating hydroxychloroquine, lopinavir-ritonavir, or dexamethasone for covid-19 : meta-epidemiological study

enthalten in: BMJ (Clinical research ed.) | 2022

von Moneer, O. | Daly, G. | Skydel, J. | +4

76

Hospital compounding to face shortage : A case study of the development of a lopinavir-ritonavir oral suspension during the first wave of SARS-COV-2 in France

enthalten in: Annales pharmaceutiques francaises | 2022

von Secretan, P. | Thirion, O. | Vieillard, V. | +4

77

Effects of Drugs Formerly Proposed for COVID-19 Treatment on Connexin43 Hemichannels

enthalten in: International journal of molecular sciences | 2022

von Cooreman, A. | Caufriez, A. | Tabernilla, A. | +7

78

Meta-analysis of arbidol versus lopinavir/ritonavir in the treatment of coronavirus disease 2019

enthalten in: Journal of medical virology | 2022

von Yu, M. | Wang, D. | Li, S. | +3

79

Predictive factors of six-week mortality in critically ill patients with SARS-CoV-2 : A multicenter prospective study

enthalten in: Medicina intensiva | 2022

von Estella, �. | Garcia Garmendia, J. | de la Fuente, C. | +39

80

Ritonavir and COVID-19 : pragmatic guidance is important

enthalten in: Lancet (London, England) | 2022

von Waters, L. | Marra, F. | Pozniak, A. | +2

CommentOn: Lancet. 2022 Jan 1;399(10319):21-22. - PMID 34973713